This site is intended for healthcare professionals only
LoginRegister
No Waiver for Faricimab: CDSCO Panel Asks Roche to Conduct Phase III Trial in IndiaRoche receives CE Mark for AI-enabled continuous glucose monitoring solution for diabetes patients
Shilpa Medicare Dabaspet unit gets VAI classification from USFDAShilpa Medicare arm Raichur API facility gets GMP Certification from ANVISA-Brazil
Revise MRP of drugs given custom duty relaxations in budget: NPPA directs Pharma Firms, MarketersNPPA Fixes Retail price of 54 formulations, Details
Darzalex receives positive EMA Committee opinion for high-risk smouldering multiple myeloma: Janssen-Cilag InternationalCOVID vaccine supply deal dispute: JnJ to pay USD 50 million to Emergent
Alembic Pharma bags USFDA nod for Bromfenac Ophthalmic SolutionAlembic Pharma bags USFDA nod for Bromfenac Ophthalmic Solution
Roche receives EU CE mark for Contivue for neovascular age-related macular degenerationRoche to reintroduce Susvimo in US for neovascular age-related macular degeneration
Eli Lilly gets USFDA Breakthrough Therapy designation for olomorasib with Keytruda for lung cancerEli Lilly to acquire Morphic for USD 3.2 billion
Sanofi gets USFDA fast track designation for neovascular age-related macular degeneration gene therapySanofi Healthcare Gets CDSCO Panel Nod to Import and Market Belumosudil Tablets
Roche receives EU CE mark for Contivue for neovascular age-related macular degenerationRoche to halt lung cancer treatment trial
G Kishan Reddy says Centre will try its best to promote pharma sector in HyderabadG Kishan Reddy says Centre will try its best to promote pharma sector in Hyderabad
Indian pharma firms seek tax incentives to boost innovationIndian pharma firms seek tax incentives to boost innovation
Graduate Pharmacy Aptitude Test- GPAT 2024 Results OUTGraduate Pharmacy Aptitude Test- GPAT 2024 Results OUT
X